CREDIT SUISSE AG/ - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 77 filers reported holding TREACE MED CONCEPTS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$650,033
-47.0%
49,583
+3.5%
0.00%0.0%
Q2 2023$1,225,819
+150.5%
47,921
+146.7%
0.00%
Q1 2023$489,265
+23.1%
19,423
+12.3%
0.00%
Q4 2022$397,543
+36.6%
17,292
+30.8%
0.00%
Q3 2022$291,000
+55.6%
13,221
+1.2%
0.00%
Q2 2022$187,000
-6.0%
13,060
+24.0%
0.00%
Q1 2022$199,00010,5360.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,907,823$25,011,5602.31%
FORMULA GROWTH LTD 222,269$2,913,9470.99%
EMERALD MUTUAL FUND ADVISERS TRUST 1,193,939$15,652,5400.94%
EMERALD ADVISERS, LLC 1,473,281$19,314,7130.94%
Perceptive Advisors 1,834,060$24,044,5270.80%
NEXT CENTURY GROWTH INVESTORS LLC 512,738$6,721,9950.73%
OBERWEIS ASSET MANAGEMENT INC/ 355,600$4,661,9160.50%
Novo Holdings A/S 360,000$4,719,6000.35%
TimesSquare Capital Management, LLC 1,433,429$18,7920.29%
KORNITZER CAPITAL MANAGEMENT INC /KS 677,733$8,885,0800.18%
View complete list of TREACE MED CONCEPTS INC shareholders